BioByte 045: partnership strategy user-manual biotechs, IRA's first drug list, epigenetic drivers of glioma, in vivo perturb-seq, synthetic data for clinical AI
BioByte 045: partnership strategy user-manual biotechs, IRA's first drug list, epigenetic drivers of glioma, in vivo perturb-seq, synthetic data for clinical AI
Welcome to Decoding Bio, a writing collective focused on the latest scientific advancements, news, and people building at the intersection of tech x bio. If you’d like to connect or collaborate, please shoot us a note here or chat with us on Twitter: @
BioByte 045: partnership strategy user-manual biotechs, IRA's first drug list, epigenetic drivers of glioma, in vivo perturb-seq, synthetic data for clinical AI
"all startups are hard and likely to fail, so you should build one with the largest scale of ambition and value capture that you believe in.” I love this quote. It call for founders and entrepreneurs to aim high and pursue ambitious goals, even in the face of obstacles. I am no founder but that quote goes hard 😆
BioByte 045: partnership strategy user-manual biotechs, IRA's first drug list, epigenetic drivers of glioma, in vivo perturb-seq, synthetic data for clinical AI
"all startups are hard and likely to fail, so you should build one with the largest scale of ambition and value capture that you believe in.” I love this quote. It call for founders and entrepreneurs to aim high and pursue ambitious goals, even in the face of obstacles. I am no founder but that quote goes hard 😆